Epidemiology of Angioid Streaks and Pseudoxanthoma Elasticum (2011–2020): a Nationwide Population-based Cohort Study

• Published in: Ophthalmology science (Online) Vol. 4; no. 2; p. 100370
• Main Authors: Wada, Saori, MD, Miyake, Masahiro, MD, PhD, Kido, Ai, MD, PhD, Kamei, Takuro, MD, Hiragi, Shusuke, MD, PhD, Ikeda, Hanako Ohashi, MD, PhD, Hata, Masayuki, MD, PhD, Ueshima, Hiroaki, PhD, Tsujikawa, Akitaka, MD, PhD, Tamura, Hiroshi, MD, PhD
• Format: Journal Article
• Language: English
• Published: Elsevier 01.03.2024
• Subjects: Ophthalmology; Original; MHLW; Prevalence; ICD-10; Angioid streaks; Claims data; CI; Epidemiology; NDB; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; Macular neovascularization; Incidence; Confidence interval; Ministry of Health, Labor and Welfare; AS; MNV; Pseudoxanthoma elasticum; National Database of Health Insurance Claims and Specific Health Checkups of Japan; PXE
• ISSN: 2666-9145; 2666-9145
• DOI: 10.1016/j.xops.2023.100370

AbstractPurposeWe aimed to describe the epidemiology of angioid streaks (AS) and pseudoxanthoma elasticum (PXE), which are rare diseases, using a national claims database. DesignThis was a population-based longitudinal cohort study. ParticipantsA total of 126 million individuals were covered by the universal health coverage system in Japan. MethodsWith permission from the Ministry of Health, Labor and Welfare (MHLW), we accessed all data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), which contains the nationwide health insurance claims data for 126 million Japanese. We identified individuals with AS and PXE between January 2011 and December 2020. The incidence rates, prevalence, overlap of AS and PXE, and mean age at death were calculated. Main Outcome MeasuresThe incidence rates and prevalence of AS and PXE. ResultsA total of 6,598 cases of AS and 1,020 cases of PXE were identified during the 10-year study period. The incidence rates of AS and PXE were 0.52 [95% CI, 0.48-0.56] and 0.08 [95% CI, 0.07-0.10] per 100 000 person-years, respectively. On October 1, 2020, the prevalence of AS and PXE was 6.5 [95% CI, 6.38-6.66] and 0.83 [95% CI, 0.78-0.89] per 100,000 persons, respectively. The overlap of AS and PXE was 363 patients. The mean age at death of individuals with AS and PXE was 79.3 ± 0.51 and 77.1 ± 2.68 years, respectively. ConclusionThis is the first population-based study to elucidate the epidemiology of AS and PXE. The mean age of death of both AS and PXE patients was younger than the mean life expectancy of the general Japanese population, thus appropriate diagnosis and management are important to avoid preventable death.